Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shobna Bhatia is active.

Publication


Featured researches published by Shobna Bhatia.


Journal of Gastroenterology and Hepatology | 2010

Asian consensus on irritable bowel syndrome.

Kok-Ann Gwee; Young-Tae Bak; Uday C. Ghoshal; Sutep Gonlachanvit; Oh Young Lee; Kwong Ming Fock; Andrew Seng Boon Chua; Ching-Liang Lu; Khean-Lee Goh; Chomsri Kositchaiwat; Govind K. Makharia; Hyojin Park; Full-Young Chang; Shin Fukudo; Myung-Gyu Choi; Shobna Bhatia; Meiyun Ke; Xh Hou; Michio Hongo

Background and Aims:  Many of the ideas on irritable bowel syndrome (IBS) are derived from studies conducted in Western societies. Their relevance to Asian societies has not been critically examined. Our objectives were to bring to attention important data from Asian studies, articulate the experience and views of our Asian experts, and provide a relevant guide on this poorly understood condition for doctors and scientists working in Asia.


Gastrointestinal Endoscopy | 1999

Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications.

Geeta H. Malkan; Shobna Bhatia; Khalid Bashir; Raju Khemani; Philip Abraham; Malan S. Gandhi; Ravikumar Radhakrishnan

BACKGROUND There are few studies of biliary changes due to portal hypertension. We ascertained the incidence of such changes on endoscopic retrograde cholangiography and determined the reliability of biochemistry, ultrasonography (US) and hepatobiliary radionuclide scan in detecting this type of cholangiopathy. METHODS Forty-two patients with portal hypertension were studied. RESULTS Cholangiopathy was detected by cholangiography in 17 of 20 patients with extrahepatic portal venous obstruction. Abnormalities (mainly strictures and caliber irregularity) were seen in the common bile duct (5) and common hepatic duct (7) and in the right (8) and left (11) hepatic ducts (mainly dilatation). One of 11 patients with noncirrhotic portal fibrosis had a dilated right hepatic duct. Three of 11 patients with cirrhosis had pruned intrahepatic ducts. Eight patients with portal venous obstruction had elevated alkaline phosphatase levels; two had elevated bilirubin levels. US detected gallbladder varices (11) and choledochal varices (9) in patients with extrahepatic portal venous obstruction. Biliary abnormalities were detected on hepatobiliary scintigraphy in 16 of 17 patients. CONCLUSIONS Cholangiopathy associated with portal hypertension occurs exclusively in patients with extrahepatic portal venous obstruction. It rarely leads to functional obstruction; jaundice does not occur in the absence of functional blockage. Elevated alkaline phosphatase level (after excluding bile duct calculi), presence of gallbladder varices on US, and abnormal radionuclide scans are reliable in detecting these lesions.


Journal of Gastroenterology and Hepatology | 2011

Current status of Barrett's esophagus research in Asia

Chi Yang Chang; Michael B. Cook; Yi-Chia Lee; Jaw-Town Lin; Takafumi Ando; Shobna Bhatia; Wong Ho Chow; Emad M. El-Omar; Hidemi Goto; Yang Qing Li; Kenneth E.L. McColl; Nageshwar Reddy; Poong-Lyul Rhee; Prateek Sharma; Joseph J.Y. Sung; Uday C. Ghoshal; Jennie Y.Y. Wong; Justin C. Wu; Jun Zhang; Khek Yu Ho

In Western countries, the epidemiology of esophageal cancer has changed considerably over the past decades with a rise in the ratio of adenocarcinoma to squamous cell carcinoma. Although the prevalence of gastroesophageal reflux is increasing in Asia, the prevalences of Barretts esophagus (BE) and esophageal adenocarcinoma (EAC) have remained low in most Asian countries. The Asian Barretts Consortium recently conducted a review of published studies on BE from Asia to assess the current status of BE research in Asia, and to recommend potential areas for future BE research in the region. Differences in study design, enrolled population, and endoscopic biopsy protocols used have led to substantial variability in the reported BE prevalence (0.06% to 19.9%) across Asia. In particular, some Japanese studies used diagnostic criteria that differed considerably from what was used in most Asian studies. As in Western countries, increased age, male sex, tobacco smoking, reflux symptoms, and erosive esophagitis have been found to be risk factors for BE in several case‐control studies from Asia. The Prague C and M criteria, developed to provide better interobserver reliability in diagnosis and grading of BE, are currently under extensive evaluation in the Asian population. There is a need for standardized protocols for endoscopic and histopathologic diagnosis before initiating collaborative projects to identify etiologic determinants of BE and its ensuing malignant transformation. At present, data regarding the management and long‐term outcome of BE are extremely limited in Asia. More studies of BE in this geographic area are warranted.


Indian Journal of Gastroenterology | 2011

Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force.

Shobna Bhatia; D. Nageshwar Reddy; Uday C. Ghoshal; V. Jayanthi; Philip Abraham; Gourdas Choudhuri; S. L. Broor; Vineet Ahuja; Philip Augustine; Vallath Balakrishnan; Deepak K. Bhasin; Naresh Bhat; Ashok Chacko; Sunil Dadhich; Gopal K. Dhali; Pankaj Dhawan; Manisha Dwivedi; Goenka Mk; Abraham Koshy; Ajay Kumar; Sri Prakash Misra; Shrikant Mukewar; E. PedaVeer Raju; K. T. Shenoy; S. P. Singh; Ajit Sood; R. Srinivasan

BackgroundGastroesophageal reflux disease (GERD) and its complications are thought to be infrequent in India; there are no data from India on the prevalence of and risk factors for GERD. The Indian Society of Gastroenterology formed a task force aiming to study: (a) the frequency and profile of GERD in India, (b) factors including diet associated with GERD.MethodsIn this prospective, multi-center (12 centers) study, data were obtained using a questionnaire from 3224 subjects regarding the frequency, severity and duration of heartburn, regurgitation and other symptoms of GERD. Data were also obtained regarding their dietary habits, addictions, and lifestyle, and whether any of these were related or had been altered because of symptoms. Data were analyzed using univariate and multivariate methods.ResultsTwo hundred and forty-five (7.6%) of 3224 subjects had heartburn and/or regurgitation at least once a week. On univariate analysis, older age (OR 1.012; 95% CI 1.003–1.021), consumption of non-vegetarian and fried foods, aerated drinks, tea/coffee were associated with GERD. Frequency of smoking was similar among subjects with or without GERD. Body mass index (BMI) was similar in subjects with and without GERD. On multivariate analysis, consumption of non-vegetarian food was independently associated with GERD symptoms. Overlap with symptoms of irritable bowel syndrome was not uncommon; 21% reported difficulty in passage of stool and 9% had mucus in stools. About 25% of patients had consulted a doctor previously for their gastrointestinal symptoms.Conclusion7.6% of Indian subjects have significant GERD symptoms. Consumption of non-vegetarian foods was an independent predictor of GERD. BMI was comparable among subjects with or without GERD.


Gut | 2016

Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus

Kwong Ming Fock; Nicholas J. Talley; Khean-Lee Goh; Kentaro Sugano; Peter Katelaris; Gerald Holtmann; John E. Pandolfino; Prateek Sharma; Tiing Leong Ang; Michio Hongo; Justin C. Wu; Minhu Chen; Myung-Gyu Choi; Ngai Moh Law; Bor-Shyang Sheu; Jun Zhang; Khek Yu Ho; Jose D. Sollano; Abdul Aziz Rani; Chomsri Kositchaiwat; Shobna Bhatia

Objective Since the publication of the Asia-Pacific consensus on gastro-oesophageal reflux disease in 2008, there has been further scientific advancement in this field. This updated consensus focuses on proton pump inhibitor-refractory reflux disease and Barretts oesophagus. Methods A steering committee identified three areas to address: (1) burden of disease and diagnosis of reflux disease; (2) proton pump inhibitor-refractory reflux disease; (3) Barretts oesophagus. Three working groups formulated draft statements with supporting evidence. Discussions were done via email before a final face-to-face discussion. We used a Delphi consensus process, with a 70% agreement threshold, using Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria to categorise the quality of evidence and strength of recommendations. Results A total of 32 statements were proposed and 31 were accepted by consensus. A rise in the prevalence rates of gastro-oesophageal reflux disease in Asia was noted, with the majority being non-erosive reflux disease. Overweight and obesity contributed to the rise. Proton pump inhibitor-refractory reflux disease was recognised to be common. A distinction was made between refractory symptoms and refractory reflux disease, with clarification of the roles of endoscopy and functional testing summarised in two algorithms. The definition of Barretts oesophagus was revised such that a minimum length of 1 cm was required and the presence of intestinal metaplasia no longer necessary. We recommended the use of standardised endoscopic reporting and advocated endoscopic therapy for confirmed dysplasia and early cancer. Conclusions These guidelines standardise the management of patients with refractory gastro-oesophageal reflux disease and Barretts oesophagus in the Asia-Pacific region.


Journal of Gastroenterology and Hepatology | 2011

Risk factors for Barrett's esophagus in Indian patients with gastroesophageal reflux disease

Praveen Mathew; Amita Joshi; Akash Shukla; Shobna Bhatia

Background and Aims:  Barretts esophagus (BE) is reported to be infrequent in Asians, with no data from India regarding its prevalence and risk factors. We investigated the frequency and risk factors of columnar mucosa with or without specialized intestinal metaplasia (SIM) in Indian patients with gastroesophageal reflux disease (GERD).


Pancreatology | 2013

A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis

Hariharan Ramesh; Nageshwar Reddy; Shobna Bhatia; J.S. Rajkumar; Amol Bapaye; Dinesh Kini; Mukesh Kalla; Vinay Thorat

BACKGROUND/OBJECTIVES To assess the efficacy and safety of pancreatin (pancrelipase) enteric-coated minimicrospheres (MMS) over a one-year period in patients with pancreatic exocrine insufficiency (PEI) due to chronic pancreatitis (CP). METHODS This was a 51-week, open-label extension (OLE) of a one-week, multicenter, double-blind, randomized, placebo-controlled trial in India that enrolled patients ≥18 years of age with confirmed PEI due to CP. Patients received pancreatin (Creon(®) 40000 MMS™) at a dose of 80,000 Ph. Eur. lipase units with each of three main meals/day and 40,000 with each of up to three snacks/day. RESULTS Of 61 patients entering the OLE, 48 completed treatment (nine were lost to follow up, two withdrew consent, one discontinued due to adverse event [acute exacerbation of CP], one protocol violation). There were significant improvements from baseline to end of OLE in mean ± SD coefficient of fat absorption (CFA: 22.7 ± 12.2%), coefficient of nitrogen absorption (CNA: 6.5 ± 7.9%), body weight (4.9 ± 4.9 kg), BMI (1.9 ± 1.9 kg/m(2)), and most nutritional laboratory parameters tested (p ≤ 0.001). Mean daily stool frequency was reduced from 2.8 to 1.6 (p < 0.001). Improvements in clinical symptoms, clinical global impression of disease symptoms, and quality of life were also observed. Treatment-emergent adverse events (TEAEs) were observed in 64% of patients overall. Only 13% of patients experienced TEAEs judged treatment related. CONCLUSIONS In patients with PEI due to CP, treatment with pancreatin for one year was associated with significant improvements in fat absorption, nitrogen absorption, and nutritional parameters, improvements in clinical symptoms, and a favorable safety and tolerability profile.


Indian Journal of Gastroenterology | 2012

Indian Society of Gastroenterology consensus on ulcerative colitis

Balakrishnan S. Ramakrishna; Govind K. Makharia; Philip Abraham; Uday C. Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K. Bhasin; Shobna Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sk Issar; Ajay K. Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C. Ganesh Pai; Sujoy Pal; Anna B. Pulimood; Amarender Singh Puri; G. N. Ramesh; Gautam Ray; Shivaram P. Singh; Ajit Sood; Manu Tandan

In 2010, the Indian Society of Gastroenterology’s Task Force on Inflammatory Bowel Diseases undertook an exercise to produce consensus statements on ulcerative colitis. This consensus, produced through a modified Delphi process, reflects our current understanding of the definition, diagnostic work up, treatment and complications of ulcerative colitis. The consensus statements are intended to serve as a reference point for teaching, clinical practice, and research in India.


Journal of Gastroenterology and Hepatology | 2016

Acute‐on‐chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience

Vivek A. Saraswat; Shivaram Prasad Singh; Ajay Duseja; Akash Shukla; C. E. Eapen; Dharmendra Kumar; Gaurav Pandey; Jayanti Venkataraman; Pankaj Puri; Krishnasamy Narayanswami; Radha K. Dhiman; Sandeep Thareja; Sandeep Nijhawan; Shobna Bhatia; Uday Zachariah; Ujjwal Sonika; Thomas Varghese; Subrat K. Acharya

The aim of this study was to analyze etiologies and frequency of hepatic and extrahepatic organ failures (OFs) and outcome of acute‐on‐chronic liver failure (ACLF) at 10 tertiary centers in India.


Diseases of The Colon & Rectum | 1996

Existence of a high pressure zone at the rectosigmoid junction in normal Indian men

Rajkumar P. Wadhwa; Mistry Fp; Shobna Bhatia; Philip Abraham

PURPOSE: A hypertonic, electrically hyperactive segment has been described in the rectosigmoid region mainly in constipated persons. Anatomic or manometric evidence to satisfy the criteria for a sphincter here is, however, inconclusive. We evaluated the pressure profile of the rectosigmoid region in normal Indian men. METHODS: Fifteen male volunteers with regular bowel habits were studied. Rectosigmoid manometry (1 cm station pull-through) was done in the fasting state using a water-perfused system and three-lumen catheter with radially oriented recording ports 5 cm apart. RESULTS: Eight volunteers had a zone of high pressure. Proximal extent of this zone was identified as the station with a rise in basal pressure of at least 10 mmHg over the previous station. A further rise of at least 10 mmHg in subsequent distal stations was considered essential for defining the existence of the zone. This zone had a median length of 3 cm, with midpoint at median 18 cm from the anal verge and median highest pressure of 36 mmHg. There was no antegrade pressure gradient across the zone; rectal pressures were higher than those in the sigmoid in 12 of 15 volunteers. CONCLUSIONS: Approximately one-half of normal Indian men with regular bowel habits have a high pressure zone in the rectosigmoid region. The role of diet or defecation posture in its etiology and its effect on bowel habit need to be studied.

Collaboration


Dive into the Shobna Bhatia's collaboration.

Top Co-Authors

Avatar

Akash Shukla

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Philip Abraham

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Uday C. Ghoshal

Sanjay Gandhi Post Graduate Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Mistry Fp

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Ajit Sood

Christian Medical College

View shared research outputs
Top Co-Authors

Avatar

Amit Gupte

King Edward Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Sri Prakash Misra

Motilal Nehru Medical College

View shared research outputs
Top Co-Authors

Avatar

Gourdas Choudhuri

Sanjay Gandhi Post Graduate Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Govind K. Makharia

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Shivaram Prasad Singh

Rajendra Agricultural University

View shared research outputs
Researchain Logo
Decentralizing Knowledge